Ovarian Diseases
ISSN: 1873-894x NEW
Volume 1; 4 issues
Institutional subscription (print and online) for 2011: €486 / US$633 (including postage and handling)
Click on the subscribe button for more options, including personal subscription prices.
Status Report: First issue (volume 1:1) scheduled for 2011


Aims and Scope
Editorial Board
Submission of Manuscripts
Download flyer for this journal

Editors-in-Chief
Michael J. Birrer MD, PhD
Harvard Medical School
Gynecologic Medical Oncology
Massachusetts General Hospital Cancer Center
Boston, MA
USA
E-mail: mbirrer@partners.org

Christina Annunziata MD, PhD
Bethesda, MD
USA

Associate Editors
John H. Farley MD
Department of Obstetrics and Gynecology
Uniformed Services University of the Health Sciences
Bethesda, MD
USA

Andrew K. Godwin (for reviews) PhD
Department of Medical Oncology
Fox Chase Cancer Center (FCCC)
Philadelphia, PA
USA

Charlie Gourley MD
Department of Clinical Oncology
Edinburgh Cancer Centre
Edinburgh
United Kingdom

Kenneth P. Nephew PhD
Department of Medical Sciences
Indiana University
Bloomington, IN
USA

 
Editorial Board
David Bowtell, MD, PhD, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia Francesco Orio, MD, PhD, University Parthenope, Naples, Italy
Evanthia Diamanti-Kandarakis, MD, University of Athens, Medical School, Athens, Greece Andres Poveda, MD, Department of Medical Oncology, Fundacion Instituto Valenciano de Oncologia, Valencia, Spain
Keiichi Fujiwara, MD, PhD, Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Hidaka-City, Japan Bo R. Rueda, PhD, Vincent Center for Reproductive Biology, Massachusetts General Hospital, Boston, MA, USA
David Gershensen, MD, Department of Gynecologic Oncology, University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA Anil Sood, MD, PhD, Departments of Gynecologic Oncology and Cancer Biology, M.D. Anderson Cancer Center, Houston, TX, USA
David Huntsman, MD, Center for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, BC, Canada Pamela Stratton, MD, Reproductive Biology and Medicine Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA
Steven A. Narod, MD, Women's College Research Institute, Toronto, ONT, Canada Edward Trimble, MD, National Cancer Institute, National Institutes of Health, Rockville, MD, USA

Submission of Manuscripts 
See instructions to authors.
Aims and Scope 
The purpose of the journal is to educate researchers and clinicians about our rapidly evolving understanding of the biology of the ovary. The recent revolution in biomedical technologies including genomics, proteomics, imaging, metabolomics and systems biology has provided a new view of the complexities of this organ. The evolving information include discoveries in the reproductive functions of the ovary, hormone production, and epithelial-stroma interactions. Investigators will be required to comprehend these new results and be able to place them in the context of the biologic interactions present in this organ and the clinical manifestations of these diseases.
The journal will focus on publishing a range of articles extending from original research to review papers. Each issue will present a series of articles focused on a single general topic.

The topics to be presented and discussed include:
- The development and progression of malignant diseases of the ovary;
- Preneoplastic diseases of the ovary;
- Benign cysts of the ovary;
- Identification biomarkers of ovarian disease;
- New techniques for studying the physiology/biology of the ovary;
- Imaging of the ovary;
- Population studies of genetic disease of the ovary;
- Mechanisms of ovarian failure;
- Animal models of ovarian diseases;
- Ovarian development;
- Novel treatments for ovarian failure.


IOS Press
Nieuwe Hemweg 6B, 1013 BG Amsterdam, The Netherlands
Tel.: +31 20 688 3355, Fax: +31 20 687 0019
E-mail: info@iospress.nl